Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
09/2000
09/05/2000US6114359 Endothelin receptor antagonists
09/05/2000US6114354 N-substituted azaheterocyclic compounds
09/05/2000US6114343 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-flurocytosin-1-yl)-1,3-oxathiolane
09/05/2000US6114335 Benzoylguanidine derivatives, process for their preparation their use in the preparation of medicines
09/05/2000US6114334 Piperazine derivatives as therapeutic agents
09/05/2000US6114330 Substituted 2,4-diaminopyrimidines
09/05/2000CA2002242C Selective monoepoxidation of styrene, styrene analogs, and styrene derivatives to the corresponding oxide with molecular oxygen
09/05/2000CA2001160C Pyridine derivatives
08/2000
08/31/2000WO2000050422A1 Process for the production of paroxetine
08/31/2000WO2000050421A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, method for producing them and their use as medicaments
08/31/2000WO2000050397A1 Substituted piperidinedione derivatives and herbicide
08/31/2000WO2000050396A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
08/31/2000WO2000050390A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
08/31/2000WO2000040558A8 Aspartic protease inhibitors
08/31/2000WO2000012074A3 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
08/31/2000DE19908699A1 Preparation of 2-aryl-1,3-ketoenol compounds, which may be useful as insecticides, by reaction of ketene compound with ketone, thioketone or imine
08/31/2000DE19908567A1 New 4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors, polyps or respiratory or gastrointestinal diseases
08/31/2000CA2371876A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
08/31/2000CA2364804A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
08/31/2000CA2361758A1 Process for the production of paroxetine
08/30/2000EP1031563A1 Sulfonyl derivatives
08/30/2000EP1030843A1 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
08/30/2000EP1030841A1 Process for the preparation of 1,4-dihydropyridines and compounds used in this process
08/30/2000EP1030840A1 Cyclic amine derivatives and their use as drugs
08/30/2000EP1030838A1 Method of synthesis of pyrrole amides
08/30/2000EP1030836A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
08/30/2000EP1030835A2 Urea derivatives and their use as integrin inhibitors
08/30/2000EP0821680B1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
08/30/2000EP0710367B1 Photochromic substituted naphthopyran compounds
08/30/2000CN1265107A Indole and 2,3-dihydronindole derivatives, their prepn. and use
08/30/2000CN1265097A Pyrrolidine carboxylic acid derivatives as endothelin antagonists
08/30/2000CN1265033A Certain diarylimidaozle derivatives, new class of NPY speific ligands
08/29/2000US6111104 Pulverizing the solvent-washed crystal particles while evaporating solvent and epichlorohydrin reactant from the surfaces of the particles, e.g. machine pulverization in a gas stream.
08/29/2000US6111103 Diresorcinyl-alkoxy- and -aryloxy-s-triazines
08/29/2000US6110963 Aryl-oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
08/29/2000US6110959 Carboxylic acid derivatives having fused rings
08/29/2000US6110956 N-aryloxyethylamine derivatives for the treatment of depression
08/29/2000US6110953 A therapeutic drug mixture comprising a 1h-1,2,4-triazole with a chemotherapeutic agents can both reduce and suppress the growth of cancers, tumors and leukemia; synergistic effect
08/29/2000US6110947 An analgesic agent for treating stroke, abdominal pain; as antiinflammatory, diuretic, anesthetic or neuroprotective agents
08/29/2000US6110939 As a substance p antagonists treating tachykinin-mediated disease, asthma, central nervous system disorder
08/29/2000US6110938 1-(arylthioalkyl, arylaminoalkyl or arylmethylenealkyl)-4-(heteroaryl)piperidines and related compounds useful as antipsychotics and analgesics
08/29/2000US6110936 A bactericide treating a bacterial infection in a warm blooded animal
08/29/2000US6110924 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
08/29/2000US6110922 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
08/29/2000US6110910 Antiinflammatory agents, antiarthritic agents, antirheumatic agents, anticarcinogenic agents
08/29/2000US6110872 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
08/29/2000CA2012628C New fluoro-4 benzoic derivatives, process for their preparation and pharmaceutical compositions containing them
08/24/2000WO2000049021A2 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/24/2000WO2000049019A2 Novel epothilone derivatives, method for producing them and their pharmaceutical use
08/24/2000WO2000049014A1 Process for the production of tert-butyl (e)-(6-[2- [4-(4-fluorophenyl) -6-isopropyl-2-[ methyl (methylsulfonyl) amino] pyrimidin-5-yl] vinyl](4r, 6s)-2,2-dimethyl [1,3]dioxan-4-yl) acetate
08/24/2000WO2000049011A1 Prothease inhibitors
08/24/2000WO2000049000A1 Dopamine d1 receptor agonist compounds
08/24/2000WO2000048997A1 SUBSTITUTED ACETYLPYRIDINE DERIVATIVES AND PROCESS FOR THE PREPARATION OF INTERMEDIATES FOR OPTICALLY ACTIVE β3 AGONIST BY THE USE OF THE SAME
08/24/2000WO2000031051B1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
08/24/2000DE19908765A1 New, chemically and metabolically stable 16-halo or cyano-epothilone derivatives are cell division regulators useful e.g. for treating malignant tumors or chronic inflammatory disease
08/24/2000DE19908760A1 New, chemically and metabolically stable epothilon derivatives having modified macrocyclic ring, useful e.g. for treating malignant tumors or chronic inflammatory disease, are cell division regulators
08/24/2000DE19907874A1 New N-substituted hexahydro-2,6-methano-3-benzazocin-10-ol derivatives, as tension-dependent sodium channel blockers useful for treating e.g. arrhythmia, spasms, pain or neurodegenerative diseases
08/24/2000CA2363695A1 Dopamine d1 receptor agonist compounds
08/24/2000CA2362070A1 Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active .beta.3 agonist by the use of the same
08/24/2000CA2361278A1 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/23/2000EP1029865A2 Process and intermediates for preparing 5-lipoxygenase inhibitors
08/23/2000EP1029860A1 Benzofuran derivatives
08/23/2000EP1029859A1 N,N'-Disubstituted unsymmetrical cyclic urea and its use in therapy
08/23/2000EP1029853A1 Heteroaromatic bicyclic derivatives useful as anticancer agents
08/23/2000EP1028955A1 Pyrimidinone compounds and pharmaceutical compositions containing them
08/23/2000EP1028953A1 Aromatic heterocyclic compounds as anti-inflammatory agents
08/23/2000EP1028951A1 Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors
08/23/2000EP1028949A1 Carbamoylphenylsulfonyl ureas, method for their production and their application as herbicides and plant growth regulators
08/23/2000EP1028948A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
08/23/2000EP1028945A1 Substituted pyridine compounds as anti-inflammatory agents
08/23/2000EP1028944A1 Fluorinated naphthalene derivatives and their use in liquid crystal mixtures
08/23/2000EP1028942A2 Dipeptide nitriles
08/23/2000EP1028730A1 Compositions of lipid lowering agents
08/23/2000EP0828734B1 Triazolyl methyl oxiranes
08/23/2000EP0637297B1 Compounds having selectivity for retinoid x receptors
08/23/2000CN1264379A Piperazine derivatives
08/23/2000CN1264377A Substituted pyrazoles as P38 kinase inhabitors
08/23/2000CN1264368A Polyhydroxybutylpyrazines, their preparation and medicines containing them
08/23/2000CN1055684C Method for preparing substituted pyridine
08/22/2000US6107503 Asymmetric zirconium catalyst
08/22/2000US6107329 Hypotensive agents; cardiovascular disorders
08/22/2000US6107322 Pesticidal 1-polyarylimidazoles
08/22/2000US6107314 Pesticides
08/22/2000US6107312 Bactericide
08/22/2000US6107311 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
08/22/2000US6107309 Hemoregulatory compounds
08/22/2000US6107301 1N-alkyl-N-arylpyrimidinamines and derivatives thereof
08/22/2000US6107295 Arylalkanoyl pyridazines
08/22/2000US6107291 Antiinflammatory agent
08/22/2000US6107024 Using 1,2-dioxetane derivative substrate in enzyme-linked assay where enzyme is linked to antigen, antibody, hapten or nucleic acid; forms aryloxide intermediate when triggered, then releases energy to form light and two carbonyl compounds
08/22/2000US6106864 Pharmaceutical formulations containing darifenacin
08/22/2000CA2176973C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/22/2000CA2085987C Piperidyl-substituted indoles
08/17/2000WO2000047584A2 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
08/17/2000WO2000047576A1 Cinnamide derivatives as orexin-1 receptors antagonists
08/17/2000WO2000047559A2 5-ht1f agonists
08/17/2000WO2000047558A1 Amide compounds and medicinal use thereof
08/17/2000WO2000047212A1 Quinazoline derivatives as angiogenesis inhibitors
08/17/2000WO2000047207A1 LACTAM INHIBITORS OF FXa AND METHOD
08/17/2000WO2000027819A3 Antrhranilic acid amides and the use thereof as medicaments